NEW YORK (GenomeWeb News) - Geospiza has won a Small Business Innovation Research grant from the National Human Genome Research Institute to fund genomic analysis software development, the company said today.
The Seattle-based company plans to use the Phase I grant to develop software that will be used in detecting rare mutations found in certain cancer types and to help make treatment decisions.
"New sequencing technologies are advancing at a significant pace and the instrument vendors are making tremendous progress in developing a wide range of applications that will change how we examine gene expression and study how variations in DNA sequences cause disease and impact health," Geospiza CSO Todd Smith said in a statement.
"This award will help us conduct important research to develop new methods to support resequencing applications," he added.
Geospiza did not disclose the amount of the grant, but standard Phase I SBIR awards last up to six months and grant as much as $100,000.